litlas
Log inCreate account

Michael B. Sporn

Active 1961–2022

278
Papers
89,134
Citations
156
h-index
278
i10-index

Citations

Citations per year for Michael B. Sporn1967: 8 citations1968: 4 citations1969: 4 citations1970: 10 citations1971: 12 citations1972: 10 citations1973: 11 citations1974: 20 citations1975: 8 citations1976: 10 citations1977: 17 citations1978: 32 citations1979: 40 citations1980: 78 citations1981: 66 citations1982: 63 citations1983: 112 citations1984: 153 citations1985: 213 citations1986: 404 citations1987: 648 citations1988: 939 citations1989: 1,109 citations1990: 1,369 citations1991: 1,204 citations1992: 1,085 citations1993: 1,100 citations1994: 936 citations1995: 866 citations1996: 875 citations1997: 896 citations1998: 936 citations1999: 983 citations2000: 932 citations2001: 787 citations2002: 805 citations2003: 780 citations2004: 676 citations2005: 686 citations2006: 610 citations2007: 635 citations2008: 599 citations2009: 615 citations2010: 544 citations2011: 565 citations2012: 673 citations2013: 517 citations2014: 484 citations2015: 428 citations2016: 401 citations2017: 339 citations2018: 301 citations2019: 817 citations2020: 969 citations2021: 812 citations2022: 563 citations2023: 441 citations2024: 602 citations2025: 240 citations2026: 8 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 9,051 citing papers, 41.9% of this breakdownChina: 1,401 citing papers, 6.5% of this breakdownUnited Kingdom: 1,370 citing papers, 6.3% of this breakdownJapan: 1,156 citing papers, 5.4% of this breakdownGermany: 1,103 citing papers, 5.1% of this breakdownCanada: 681 citing papers, 3.2% of this breakdownItaly: 670 citing papers, 3.1% of this breakdownFrance: 603 citing papers, 2.8% of this breakdownAustralia: 457 citing papers, 2.1% of this breakdownNetherlands: 385 citing papers, 1.8% of this breakdownSouth Korea: 368 citing papers, 1.7% of this breakdownIndia: 362 citing papers, 1.7% of this breakdown
0%41.9%Other 18.4%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology42%
  • Medicine40.9%
  • Immunology and Microbiology7.8%
  • Neuroscience3.5%
  • Engineering1.1%
  • Agricultural and Biological Sciences0.9%
  • Other3.8%

Topics

  • TGF-β signaling in diseases4.7%
  • Genomics, phytochemicals, and oxidative stress2.7%
  • Cell Adhesion Molecules Research1.9%
  • Retinoids in leukemia and cellular processes1.6%
  • Wound Healing and Treatments1.3%
  • Antioxidant Activity and Oxidative Stress1.3%
  • Other86.5%

Coauthors

All papers

Open in search
  1. NRF2 and cancer: the good, the bad and the importance of context

    Authors: Michael B. Sporn, Karen T. Liby - Nature reviews. Cancer 2012 cited by 1,052

  2. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.

    Authors: A B Kulkarni, C G Huh, Daniel M. Becker, Andrew G. Geiser, M Lyght, Kathleen C. Flanders, Alistair B. Roberts, Michael B. Sporn, Jerrold M. Ward, Stefan Karlsson - National Academy of Sciences, Proceedings of the National Academy of Sciences 1993 cited by 1,952

  3. Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress

    Authors: Albena T. Dinkova‐Kostova, Karen T. Liby, Katherine K. Stephenson, W. David Holtzclaw, Xiangqun Gao, Nanjoo Suh, Charlotte R. Williams, Renee Risingsong, Tadashi Honda, Gordon W. Gribble, Michael B. Sporn, Paul Talalay - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 566

  4. Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

    Authors: Tangying Lu, Rupal Ramakrishnan, Soner Altiok, Je In Youn, Pingyan Cheng, Esteban Celis, В. М. Писарев, Simon Sherman, Michael B. Sporn, Dmitry I. Gabrilovich - Journal of Clinical Investigation 2011 cited by 361

  5. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

    Authors: Anita B. Roberts, Michael B. Sporn, Richard K. Assoian, Joseph M. Smith, N S Roche, Lalage M. Wakefield, Ursula Heine, L A Liotta, Vincent Falanga, John H. Kehrl - National Academy of Sciences, Proceedings of the National Academy of Sciences 1986 cited by 2,880

  6. Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease

    Authors: Karen T. Liby, Michael B. Sporn - Pharmacological Reviews 2012 cited by 406

  7. The tumour microenvironment as a target for chemoprevention

    Authors: Adriana Albini, Michael B. Sporn - Nature reviews. Cancer 2007 cited by 820

  8. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.

    Authors: Richard K. Assoian, Akira Komoriya, Chester A. Meyers, Dorothea M. Miller, Michael B. Sporn - Journal of Biological Chemistry 1983 cited by 1,602

  9. New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress

    Authors: Michael B. Sporn, Karen T. Liby, Mark M. Yore, Liangfeng Fu, Justin M. Lopchuk, Gordon W. Gribble - Journal of Natural Products 2011 cited by 313

  10. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer

    Authors: Karen T. Liby, Mark M. Yore, Michael B. Sporn - Nature reviews. Cancer 2007 cited by 637

  11. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis

    Authors: Arie Neymotin, Noel Y. Calingasan, Elizabeth Wille, Nima Naseri, Susanne Petri, Maria Damiano, Karen T. Liby, Renee Risingsong, Michael B. Sporn, M. Flint Beal, Mahmoud Kiaei - Free Radical Biology and Medicine 2011 cited by 215

  12. Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease

    Authors: Cliona Stack, Daniel Ho, Elizabeth Wille, Noel Y. Calingasan, Charlotte R. Williams, Karen T. Liby, Michael B. Sporn, Magali Dumont, M. Flint Beal - Free Radical Biology and Medicine 2010 cited by 172

  13. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.

    Authors: Sharon M. Wahl, D A Hunt, Lalage M. Wakefield, Nancy McCartney‐Francis, L M Wahl, Anita B. Roberts, Michael B. Sporn - National Academy of Sciences, Proceedings of the National Academy of Sciences 1987 cited by 1,281

  14. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide

    Authors: Rajesh K. Thimmulappa, Catherine Scollick, Kassim Traore, Melinda S. Yates, Michael A. Trush, Karen T. Liby, Michael B. Sporn, Masayuki Yamamoto, Thomas W. Kensler, Shyam Biswal - Biochemical and Biophysical Research Communications 2006 cited by 351

  15. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes

    Authors: Melinda S. Yates, Masafumi Tauchi, Fumiki Katsuoka, Kathleen C. Flanders, Karen T. Liby, Tadashi Honda, Gordon W. Gribble, Delinda A. Johnson, Jeffrey A. Johnson, Neal C. Burton, Tomás R. Guilarte, Masayuki Yamamoto, Michael B. Sporn, Thomas W. Kensler - Molecular Cancer Therapeutics 2007 cited by 293

  16. Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer

    Authors: Srinivas Nagaraj, Je-In Youn, Hannah Weber, Cristina Iclozan, Lily Lu, Matthew J. Cotter, Colin J. Meyer, Carlos Becerra, Mayer Fishman, Scott Antonia, Michael B. Sporn, Karen T. Liby, Bhupendra Rawal, Ji‐Hyun Lee, Dmitry I. Gabrilovich - Clinical Cancer Research 2010 cited by 276

  17. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues.

    Authors: Anita B. Roberts, Mario A. Anzano, Lois C. Lamb, Joseph M. Smith, Michael B. Sporn - National Academy of Sciences, Proceedings of the National Academy of Sciences 1981 cited by 915

  18. Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice

    Authors: Thomas E. Sussan, Tirumalai Rangasamy, David J. Blake, Deepti Malhotra, Hazim El‐Haddad, Djahida Bedja, Melinda S. Yates, Ponvijay Kombairaju, Masayuki Yamamoto, Karen T. Liby, Michael B. Sporn, Kathleen L. Gabrielson, Hunter C. Champion, Rubin M. Tuder, Thomas W. Kensler, Shyam Biswal - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 346

  19. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice

    Authors: Melinda S. Yates, Quynh T. Tran, Patrick M. Dolan, William O. Osburn, Soona Shin, Colin McCulloch, Jay B. Silkworth, Keiko Taguchi, Masayuki Yamamoto, Charlotte R. Williams, Karen T. Liby, Michael B. Sporn, Thomas R. Sutter, Thomas W. Kensler - Carcinogenesis 2009 cited by 266

  20. Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages

    Authors: Tadashi Honda, BarbieAnn V. Rounds, Gordon W. Gribble, Nanjoo Suh, Yongping Wang, Michael B. Sporn - Bioorganic & Medicinal Chemistry Letters 1998 cited by 204

  21. Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution.

    Authors: Lalage M. Wakefield, Thomas S. Winokur, Robin S. Hollands, Kent W. Christopherson, Arthur D. Levinson, Michael B. Sporn - Journal of Clinical Investigation 1990 cited by 317

  22. The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE Signaling

    Authors: Karen T. Liby, Thomas Hock, Mark M. Yore, Nanjoo Suh, Andrew E. Place, Renee Risingsong, Charlotte R. Williams, Darlene B. Royce, Tadashi Honda, Yukiko Honda, Gordon W. Gribble, Nathalie Hill‐Kapturczak, Anupam Agarwal, Michael B. Sporn - Cancer Research 2005 cited by 284

  23. Distinct Regulations of HO-1 Gene Expression for Stress Response and Substrate Induction

    Authors: Anqi Zhang, Takafumi Suzuki, Saki Adachi, Eriko Naganuma, Norio Suzuki, Tomonori Hosoya, Ken Itoh, Michael B. Sporn, Masayuki Yamamoto - Molecular and Cellular Biology 2021 cited by 31

  24. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.

    Authors: John H. Kehrl, Lalage M. Wakefield, Anita B. Roberts, Sonia B. Jakowlew, M Alvarez-Mon, Rik Derynck, Michael B. Sporn, Anthony S. Fauci - The Journal of Experimental Medicine 1986 cited by 1,591